AlphaMaven AlphaMaven

Benchmark Reaffirms $570 Price Target on Strategy, Citing Two-Way Capital Management - bloomingbit

Reported by Bloomingbit
Jun 30, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Benchmark maintained its Buy rating on MicroStrategy (NASDAQ: MSTR) while reaffirming a $570 price target, representing a reduction from a prior $705 target amid bitcoin volatility concerns.
  • • The analyst characterized recent MSTR selloffs as a stress test of the company's funding model rather than a fundamental breakdown, signaling confidence in the underlying business thesis.
  • • Benchmark's rating reflects conviction in MicroStrategy's bitcoin accumulation strategy and two-way capital management framework, positioning the stock for continued upside despite near-term volatility.
  • • The $570 price target implies meaningful upside potential for institutional investors evaluating exposure to bitcoin-correlated equities and alternative asset accumulation strategies.
Summary
Benchmark has reaffirmed its Buy rating on MicroStrategy stock with a $570 price target, according to analyst Mark Palmer, maintaining conviction in the company's strategy despite recent market volatility. The reaffirmed price target represents a reduction from a previously published $705 target, reflecting analyst acknowledgment of bitcoin price fluctuations and broader macro conditions affecting the cryptocurrency market. However, the maintained Buy rating underscores Benchmark's confidence that near-term weakness does not signal structural deterioration in MicroStrategy's business model or capital deployment strategy.

The analyst characterized the recent selloff in MSTR shares as a stress test of the company's funding model rather than evidence of systemic breakdown. This framing is significant for institutional investors evaluating counterparty risk and capital structure stability—Benchmark's assessment suggests that MicroStrategy's ability to raise capital and execute its bitcoin accumulation agenda remains intact despite equity market pressure. The company's two-way capital management approach, which balances opportunistic bitcoin purchases with disciplined funding mechanisms, appears central to Benchmark's ongoing positive thesis on the stock.

MicroStrategy's bitcoin accumulation strategy remains the core driver of Benchmark's investment case. The company has aggressively deployed capital into bitcoin holdings, leveraging both equity issuances and preferred stock offerings to finance large-scale acquisitions of the cryptocurrency. Benchmark's maintained Buy rating reflects analyst confidence that this strategy will generate substantial shareholder value as bitcoin markets recover and institutional adoption of digital assets deepens.

For alternative investment professionals and hedge fund managers, the $570 price target provides a quantified view of near-term fair value in a name that serves as a leveraged proxy to bitcoin exposure within public equities. The target implies upside from depressed levels during periods of crypto market stress, positioning MSTR as a tactical vehicle for investors seeking concentrated exposure to digital asset appreciation without direct cryptocurrency custody.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Bloomingbit Benchmark Reaffirms $570 Price Target on Strategy, Citing Two-Way Capital Management - bloomingbit